ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Omalizumab for Injection Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-30T8074
Home | Market Reports | Health| Pharmacy
Global Omalizumab for Injection Market Insights Forecast to 2028
BUY CHAPTERS

Global Omalizumab for Injection Market Research Report 2025

Code: QYRE-Auto-30T8074
Report
August 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Novartis
CSPC Pharmaceutical Group

Omalizumab for Injection Market Size

The global market for Omalizumab for Injection was valued at US$ 4352 million in the year 2024 and is projected to reach a revised size of US$ 8069 million by 2031, growing at a CAGR of 9.1% during the forecast period.

Omalizumab for Injection Market

Omalizumab for Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Omalizumab for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Omalizumab for Injection is a monoclonal antibody used primarily for the treatment of moderate to severe allergic asthma and chronic spontaneous urticaria. It works by specifically binding to immunoglobulin E (IgE), preventing IgE from interacting with its receptor, thereby inhibiting allergic and inflammatory responses. The medication is typically administered via subcutaneous injection and can improve symptoms and reduce acute exacerbations in long-term clinical management. In 2024, the global sales volume of Omalizumab for Injection reached approximately 26.39 million units, with an average price of 165 USD per unit.
Market Overview
The Omalizumab Injection market has maintained steady growth in recent years, driven by increasing demand for effective biologics among patients with allergic asthma and chronic spontaneous urticaria. Expansion of clinical guideline recommendations and long-term treatment protocols has improved market coverage, while the drug’s benefits in symptom management and prevention of acute exacerbations have contributed to overall market growth.
Regional Market Landscape
Globally, the United States accounts for 50% of the market, Europe 30%, Asia 15%, and other regions 5%, reflecting a market structure centered on North America with Europe following closely, while the Asian market is gradually expanding and emerging as a new growth area.
Key Manufacturers and Industry Competition
Roche and Novartis hold dominant positions as the primary developers and manufacturers worldwide, but competition is gradually intensifying with the emergence of biosimilars and other monoclonal antibodies. Companies maintain competitive advantages through scale expansion, global distribution networks, and clinical collaboration strategies, while enhancing product accessibility and patient coverage.
Technological Trends and Innovation Directions
Technological innovations focus on antibody structure optimization, development of long-acting formulations, and convenient delivery system design, which improve stability and patient adherence while supporting new indication expansion and combination therapy strategies. R&D progress is accelerating clinical application and market penetration.
Policy and Industry Development Drivers
Market development is driven by healthcare policy support, allergic disease prevention strategies, and optimized regulatory approvals for biologics. Clinical guideline recommendations and patient demand for innovative therapies further promote market expansion, while policy and public health factors jointly support long-term growth potential.
Future Outlook
Looking ahead, the Omalizumab Injection market is expected to maintain steady growth amid increasing global demand for allergic disease treatments, with potential increases in market concentration. Expansion into new indications, development of long-acting formulations, and regional market penetration will serve as key growth drivers. Technological innovation, policy support, and clinical adoption will collectively shape the long-term development landscape.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Omalizumab for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Omalizumab for Injection.
The Omalizumab for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Omalizumab for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Omalizumab for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Omalizumab for Injection Market Report

Report Metric Details
Report Name Omalizumab for Injection Market
Accounted market size in year US$ 4352 million
Forecasted market size in 2031 US$ 8069 million
CAGR 9.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Subcutaneous Powder For Injection
  • Subcutaneous Solution (150 mg/mL)
  • Subcutaneous Solution(75 mg/0.5 mL)
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Novartis, CSPC Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Omalizumab for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Omalizumab for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Omalizumab for Injection Market growing?

Ans: The Omalizumab for Injection Market witnessing a CAGR of 9.1% during the forecast period 2025-2031.

What is the Omalizumab for Injection Market size in 2031?

Ans: The Omalizumab for Injection Market size in 2031 will be US$ 8069 million.

What is the Omalizumab for Injection Market share by region?

Ans: Regional Market Landscape Globally, the United States accounts for 50% of the market, Europe 30%, Asia 15%, and other regions 5%, reflecting a market structure centered on North America with Europe following closely, while the Asian market is gradually expanding and emerging as a new growth area.

Who are the main players in the Omalizumab for Injection Market report?

Ans: The main players in the Omalizumab for Injection Market are Roche, Novartis, CSPC Pharmaceutical Group

What are the Application segmentation covered in the Omalizumab for Injection Market report?

Ans: The Applications covered in the Omalizumab for Injection Market report are Hospital, Clinic

What are the Type segmentation covered in the Omalizumab for Injection Market report?

Ans: The Types covered in the Omalizumab for Injection Market report are Subcutaneous Powder For Injection, Subcutaneous Solution (150 mg/mL), Subcutaneous Solution(75 mg/0.5 mL)

1 Omalizumab for Injection Market Overview
1.1 Product Definition
1.2 Omalizumab for Injection by Type
1.2.1 Global Omalizumab for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Subcutaneous Powder For Injection
1.2.3 Subcutaneous Solution (150 mg/mL)
1.2.4 Subcutaneous Solution(75 mg/0.5 mL)
1.3 Omalizumab for Injection by Application
1.3.1 Global Omalizumab for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Omalizumab for Injection Market Size Estimates and Forecasts
1.4.1 Global Omalizumab for Injection Revenue 2020-2031
1.4.2 Global Omalizumab for Injection Sales 2020-2031
1.4.3 Global Omalizumab for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Omalizumab for Injection Market Competition by Manufacturers
2.1 Global Omalizumab for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Omalizumab for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Omalizumab for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Omalizumab for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Omalizumab for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Omalizumab for Injection, Product Type & Application
2.7 Global Key Manufacturers of Omalizumab for Injection, Date of Enter into This Industry
2.8 Global Omalizumab for Injection Market Competitive Situation and Trends
2.8.1 Global Omalizumab for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Omalizumab for Injection Players Market Share by Revenue
2.8.3 Global Omalizumab for Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Omalizumab for Injection Market Scenario by Region
3.1 Global Omalizumab for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Omalizumab for Injection Sales by Region: 2020-2031
3.2.1 Global Omalizumab for Injection Sales by Region: 2020-2025
3.2.2 Global Omalizumab for Injection Sales by Region: 2026-2031
3.3 Global Omalizumab for Injection Revenue by Region: 2020-2031
3.3.1 Global Omalizumab for Injection Revenue by Region: 2020-2025
3.3.2 Global Omalizumab for Injection Revenue by Region: 2026-2031
3.4 North America Omalizumab for Injection Market Facts & Figures by Country
3.4.1 North America Omalizumab for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Omalizumab for Injection Sales by Country (2020-2031)
3.4.3 North America Omalizumab for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Omalizumab for Injection Market Facts & Figures by Country
3.5.1 Europe Omalizumab for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Omalizumab for Injection Sales by Country (2020-2031)
3.5.3 Europe Omalizumab for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Omalizumab for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Omalizumab for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Omalizumab for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Omalizumab for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Omalizumab for Injection Market Facts & Figures by Country
3.7.1 Latin America Omalizumab for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Omalizumab for Injection Sales by Country (2020-2031)
3.7.3 Latin America Omalizumab for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Omalizumab for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Omalizumab for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Omalizumab for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Omalizumab for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Omalizumab for Injection Sales by Type (2020-2031)
4.1.1 Global Omalizumab for Injection Sales by Type (2020-2025)
4.1.2 Global Omalizumab for Injection Sales by Type (2026-2031)
4.1.3 Global Omalizumab for Injection Sales Market Share by Type (2020-2031)
4.2 Global Omalizumab for Injection Revenue by Type (2020-2031)
4.2.1 Global Omalizumab for Injection Revenue by Type (2020-2025)
4.2.2 Global Omalizumab for Injection Revenue by Type (2026-2031)
4.2.3 Global Omalizumab for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Omalizumab for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Omalizumab for Injection Sales by Application (2020-2031)
5.1.1 Global Omalizumab for Injection Sales by Application (2020-2025)
5.1.2 Global Omalizumab for Injection Sales by Application (2026-2031)
5.1.3 Global Omalizumab for Injection Sales Market Share by Application (2020-2031)
5.2 Global Omalizumab for Injection Revenue by Application (2020-2031)
5.2.1 Global Omalizumab for Injection Revenue by Application (2020-2025)
5.2.2 Global Omalizumab for Injection Revenue by Application (2026-2031)
5.2.3 Global Omalizumab for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Omalizumab for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Omalizumab for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Omalizumab for Injection Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Omalizumab for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Omalizumab for Injection Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 CSPC Pharmaceutical Group
6.3.1 CSPC Pharmaceutical Group Company Information
6.3.2 CSPC Pharmaceutical Group Description and Business Overview
6.3.3 CSPC Pharmaceutical Group Omalizumab for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSPC Pharmaceutical Group Omalizumab for Injection Product Portfolio
6.3.5 CSPC Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Omalizumab for Injection Industry Chain Analysis
7.2 Omalizumab for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Omalizumab for Injection Production Mode & Process Analysis
7.4 Omalizumab for Injection Sales and Marketing
7.4.1 Omalizumab for Injection Sales Channels
7.4.2 Omalizumab for Injection Distributors
7.5 Omalizumab for Injection Customer Analysis
8 Omalizumab for Injection Market Dynamics
8.1 Omalizumab for Injection Industry Trends
8.2 Omalizumab for Injection Market Drivers
8.3 Omalizumab for Injection Market Challenges
8.4 Omalizumab for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Novartis
CSPC Pharmaceutical Group
List of Tables
 Table 1. Global Omalizumab for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Omalizumab for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Omalizumab for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Omalizumab for Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Omalizumab for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Omalizumab for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Omalizumab for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Omalizumab for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Omalizumab for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Omalizumab for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Omalizumab for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Omalizumab for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Omalizumab for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Omalizumab for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Omalizumab for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Omalizumab for Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Omalizumab for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Omalizumab for Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Omalizumab for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Omalizumab for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Omalizumab for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Omalizumab for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Omalizumab for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Omalizumab for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Omalizumab for Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Omalizumab for Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Omalizumab for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Omalizumab for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Omalizumab for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Omalizumab for Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Omalizumab for Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Omalizumab for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Omalizumab for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Omalizumab for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Omalizumab for Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Omalizumab for Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Omalizumab for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Omalizumab for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Omalizumab for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Omalizumab for Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Omalizumab for Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Omalizumab for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Omalizumab for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Omalizumab for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Omalizumab for Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Omalizumab for Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Omalizumab for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Omalizumab for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Omalizumab for Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Omalizumab for Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Omalizumab for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Omalizumab for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Omalizumab for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Omalizumab for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Omalizumab for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Omalizumab for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Omalizumab for Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Omalizumab for Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Omalizumab for Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Omalizumab for Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Omalizumab for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Omalizumab for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Omalizumab for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Omalizumab for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Omalizumab for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Omalizumab for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Omalizumab for Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Omalizumab for Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Omalizumab for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Omalizumab for Injection Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Omalizumab for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Novartis Omalizumab for Injection Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. CSPC Pharmaceutical Group Company Information
 Table 81. CSPC Pharmaceutical Group Description and Business Overview
 Table 82. CSPC Pharmaceutical Group Omalizumab for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. CSPC Pharmaceutical Group Omalizumab for Injection Product
 Table 84. CSPC Pharmaceutical Group Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Omalizumab for Injection Distributors List
 Table 88. Omalizumab for Injection Customers List
 Table 89. Omalizumab for Injection Market Trends
 Table 90. Omalizumab for Injection Market Drivers
 Table 91. Omalizumab for Injection Market Challenges
 Table 92. Omalizumab for Injection Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Omalizumab for Injection
 Figure 2. Global Omalizumab for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Omalizumab for Injection Market Share by Type: 2024 & 2031
 Figure 4. Subcutaneous Powder For Injection Product Picture
 Figure 5. Subcutaneous Solution (150 mg/mL) Product Picture
 Figure 6. Subcutaneous Solution(75 mg/0.5 mL) Product Picture
 Figure 7. Global Omalizumab for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Omalizumab for Injection Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Global Omalizumab for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Omalizumab for Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Omalizumab for Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Omalizumab for Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Omalizumab for Injection Report Years Considered
 Figure 16. Omalizumab for Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Omalizumab for Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Omalizumab for Injection Players: Market Share by Revenue in Omalizumab for Injection in 2024
 Figure 19. Omalizumab for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Omalizumab for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Omalizumab for Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Omalizumab for Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Omalizumab for Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Omalizumab for Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Omalizumab for Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Omalizumab for Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Omalizumab for Injection Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Omalizumab for Injection Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Omalizumab for Injection Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Omalizumab for Injection Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Omalizumab for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Omalizumab for Injection by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Omalizumab for Injection by Type (2020-2031)
 Figure 55. Global Omalizumab for Injection Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Omalizumab for Injection by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Omalizumab for Injection by Application (2020-2031)
 Figure 58. Global Omalizumab for Injection Price (US$/Unit) by Application (2020-2031)
 Figure 59. Omalizumab for Injection Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Omalizumab Biosimilars Market Research Report 2025
Global Omalizumab Monoclonal Antibody Biosimilars Market Research Report 2024
Global Emicizumab Injection Market Research Report 2024
Global Asthma Immunotherapies Market Research Report 2024
Global Allergy Medicine Market Research Report 2024
Global Asthma Nebulizer Market Research Report 2025
Global Asthma Allergy Treatment Market Insights Forecast to 2030
Global Infliximab Injection Market Research Report 2024
Global Medicines for Eosinophilic Asthma Treatment Market Research Report 2025
Global Biologics for Severe Asthma Market Research Report 2024
Global Asthma Inhalers Market Research Report 2025
Long term Asthma Control Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Allergic Asthma Therapeutics Market Research Report 2025
Global Albuterol Sulfate Inhalers Market Research Report 2024
Global Albuterol Sulfate Metered Dose Inhalers Market Research Report 2024
Global Allergy Immunotherapies Market Research Report 2025
Global Asthma Medication Market Research Report 2025
Global Tislelizumab Injection Market Research Report 2024
Global Asthma Therapeutics Market Research Report 2025
Long Term Asthma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions